US FDA approves Glaukos' new eye therapy
Oct 20 (Reuters) - The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp GKOS.N, giving patients a less painful and more convenient option to treat a progressive condition that can severely affect vision, the company said on Monday. (Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary